CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 61 enrolled
Drug / intervention
No interventions - observational studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005305
NCT00005305N/ACompleted
CompareCT.gov

Prevalence and Consequences of Hepatitis Delta Virus Infection in Hemophiliacs

University of North Carolina, Chapel Hill·observational·Posted May 26, 2000·Updated Jun 14, 2016

In Brief

An observational study evaluating No interventions - observational study for Blood Disease and 3 related conditions. Completed, enrolled 61 participants.

Detailed Summary

To elucidate the role of hepatitis delta virus (HDV) in the development of chronic liver disease in patients with hemophilia.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBlood Disease, Hepatitis, Viral, Human, Liver Diseases, Hemophilia A
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
19871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartSep 1, 1987
Primary CompletionSep 1, 1991
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 26.1 years ago

Interventions

No interventions - observational studyother